Cargando…
Taking regulatory T cells into medicine
Regulatory T cells (Tregs) are indispensable for the establishment and maintenance of immunological self-tolerance. Their genetic anomalies or variations in function are causative of various monogenic and polygenic autoimmune diseases. Treg-based reestablishment of self-tolerance is envisioned to cu...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160581/ https://www.ncbi.nlm.nih.gov/pubmed/34037676 http://dx.doi.org/10.1084/jem.20210831 |
_version_ | 1783700311764893696 |
---|---|
author | Sakaguchi, Shimon |
author_facet | Sakaguchi, Shimon |
author_sort | Sakaguchi, Shimon |
collection | PubMed |
description | Regulatory T cells (Tregs) are indispensable for the establishment and maintenance of immunological self-tolerance. Their genetic anomalies or variations in function are causative of various monogenic and polygenic autoimmune diseases. Treg-based reestablishment of self-tolerance is envisioned to cure autoimmune diseases in the clinic. |
format | Online Article Text |
id | pubmed-8160581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-81605812021-12-07 Taking regulatory T cells into medicine Sakaguchi, Shimon J Exp Med Viewpoint Regulatory T cells (Tregs) are indispensable for the establishment and maintenance of immunological self-tolerance. Their genetic anomalies or variations in function are causative of various monogenic and polygenic autoimmune diseases. Treg-based reestablishment of self-tolerance is envisioned to cure autoimmune diseases in the clinic. Rockefeller University Press 2021-05-26 /pmc/articles/PMC8160581/ /pubmed/34037676 http://dx.doi.org/10.1084/jem.20210831 Text en © 2021 Sakaguchi http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Viewpoint Sakaguchi, Shimon Taking regulatory T cells into medicine |
title | Taking regulatory T cells into medicine |
title_full | Taking regulatory T cells into medicine |
title_fullStr | Taking regulatory T cells into medicine |
title_full_unstemmed | Taking regulatory T cells into medicine |
title_short | Taking regulatory T cells into medicine |
title_sort | taking regulatory t cells into medicine |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160581/ https://www.ncbi.nlm.nih.gov/pubmed/34037676 http://dx.doi.org/10.1084/jem.20210831 |
work_keys_str_mv | AT sakaguchishimon takingregulatorytcellsintomedicine |